Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Inocells B V maintains a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action under review. This activity is handled by 1 distinct examiner, indicating a singular focus for the current prosecution efforts in the cell-based technology sector.
The busiest examiner for the portfolio is MOORE, JOHN DAVID, who is managing the 1 pending office action. This individual is responsible for the total active workload currently reported for the company. The prosecution is localized within a distinct art unit.
Such a concentrated workload suggests that the company's immediate patent strategy is tied to a specific biotechnological innovation. Practitioners should prioritize clear communication with the assigned examiner, as this single point of contact will determine the outcome of the company's current pharmaceutical intellectual property efforts.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOORE, JOHN DAVID | 1 | 64.2% | +24.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916134 | COMPOSITION | MOORE, JOHN DAVID | 17d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916134 | COMPOSITION | MOORE, JOHN DAVID | 17d overdue |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17916134 | COMPOSITION | MOORE, JOHN DAVID | 1638 | §101§103 | Non-Final OA | 17d overdue | Pending | Sep 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial